Case Report
Accepted on 05 Feb 2026
Intrahepatic arterioportal fistula (IAPF) -A Rare Cause of Hemobilia
in Hepatobiliary Diseases
Frontiers in Medicine
Type at least 3 characters
408 articles
articles
Original Research
Published on 05 Feb 2026
Clinical characteristics and prognosis of patients with HBV-ACLF versus ALD-ACLF: a retrospective comparative study
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1565646
- 217 views
Mini Review
Published on 05 Feb 2026
IgG4-related sclerosing cholangitis: navigating diagnostic dilemmas and the challenge of relapse
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1732637
- 231 views
Review
Accepted on 04 Feb 2026
The Macrophage Opera: From Metabolic Prologue to Oncogenic Crescendo in Metabolic dysfunction-associated steatotic liver disease
in Hepatobiliary Diseases
Frontiers in Medicine
Review
Published on 04 Feb 2026
Harnessing mesenchymal stromal cells for liver disease therapy: from mechanistic discoveries to clinical breakthroughs
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1677021
- 319 views
Systematic Review
Published on 04 Feb 2026
Efficacy of empagliflozin in patients with metabolic dysfunction-associated steatotic liver disease with or without diabetes: a systematic review and meta-analysis of randomized controlled trials
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1712586
- 311 views
Original Research
Accepted on 03 Feb 2026
Risk factors for 1-year cirrhosis in non-cirrhotic patients with HBV-related acute-on-chronic liver failure
in Hepatobiliary Diseases
Frontiers in Medicine
Original Research
Published on 03 Feb 2026
The impact of the COVID-19 pandemic on liver health: exploring shifts in social and psychosocial determinants of steatosis and fibrosis
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1725338
- 832 views
Original Research
Accepted on 02 Feb 2026
Growth Differentiation Factor 15 (GDF-15) as a modulator of hepatic steatosis and fibrosis: Insights from a 6-Year retrospective cohort study
in Hepatobiliary Diseases
Frontiers in Medicine
Original Research
Accepted on 02 Feb 2026
Risk score to predict fibrosis among Mexican adults: results of the Health Workers Cohort Study
in Hepatobiliary Diseases
Frontiers in Medicine
Systematic Review
Published on 02 Feb 2026
Risk prediction models for hepatic encephalopathy following TIPS: a systematic review and meta-analysis
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1707035
- 261 views
Case Report
Published on 02 Feb 2026
Case Report: Percutaneous portal-central venous bypass: a novel salvage therapy for refractory variceal bleeding in TIPS-ineligible patients with portal vein tumor thrombus
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1731912
- 255 views
Case Report
Published on 02 Feb 2026
Procalcitonin as a potential tumor marker for fibrolamellar hepatocellular carcinoma: Insights from three patients and a literature review
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1718663
- 318 views
Case Report
Published on 30 Jan 2026
Case Report: Congenital gallbladder agenesis
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1778733
- 289 views
Original Research
Published on 29 Jan 2026
Association between platelet levels and bleeding events in patients with acute-on-chronic liver failure treated with an artificial liver support system
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1718780
- 350 views
Systematic Review
Accepted on 28 Jan 2026
Comparison of probiotics to lactulose for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials
in Hepatobiliary Diseases
Frontiers in Medicine
- 104 views
Original Research
Published on 27 Jan 2026
Successful long-term results (> 5 years) of superselective transarterial chemoembolization in symptomatic/enlarging liver hemangiomas: a paradigm shift at a hepatopancreatobiliary surgery unit
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1699596
- 416 views
Original Research
Accepted on 26 Jan 2026
Clinical and histopathological features of chronic hepatitis B with normal alanine aminotransferase levels with or without concomitant non-alcoholic fatty liver disease
in Hepatobiliary Diseases
Frontiers in Medicine
- 108 views
Original Research
Accepted on 26 Jan 2026
An Interpretable Machine Learning Model with SHAP Explanations Predicts Spontaneous Bleeding in Pediatric Acute Liver Failure
in Hepatobiliary Diseases
Frontiers in Medicine
Original Research
Accepted on 22 Jan 2026
Exploring the prediction model and core genes for coronary artery diseasein non-obese steatotic liver disease patients
in Hepatobiliary Diseases
Frontiers in Medicine
- 113 views
Case Report
Published on 22 Jan 2026
Experience with hepatectomy in a patient with focal nodular hyperplasia combining with constitutional indocyanine green excretory defect: a case report
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1675917
- 410 views
Original Research
Published on 22 Jan 2026
A simple score of sarcopenic obesity predicts all-cause mortality in patients with cirrhosis
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1719899
- 277 views
Original Research
Published on 21 Jan 2026
Liver fibrosis in biliary atresia: identification of the key gene EDIL3 via integrated bioinformatics
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1726141
- 510 views
Original Research
Published on 21 Jan 2026
Beyond traditional—the sick cirrhosis patient scores integrating cytokine and immune profiling for precision prognosis in hospitalized cirrhosis patients may help predict infection, ICU admission and long-term death post hospitalization
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2026.1736956
- 544 views